Hospital Universitario Miguel Servet

Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY (2023) Balmaña J, Fasching P, Couch FJ, Delaloge S, Labidi-Galy I, O’Shaughnessy J, Park YH, et al. Journal article Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: Phase IIIb LUCY final analysis (2022) Balmana J, Fasching P, Delaloge S, Park YH, Eisen A, Bourgeois H, Kemp Z, et al. Conference contribution How can we estimate QALYs based on PHQ-9 scores? Equipercentile linking analysis of PHQ-9 and EQ-5D (2021) Furukawa TA, Levine SZ, Buntrock C, Ebert DD, Gilbody S, Brabyn S, Kessler D, et al. Journal article Dismantling, optimising, and personalising internet cognitive behavioural therapy for depression: a systematic review and component network meta-analysis using individual participant data (2021) Furukawa TA, Suganuma A, Ostinelli EG, Andersson G, Beevers CG, Shumake J, Berger T, et al. Journal article Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy (2021) Dietz J, Di Maio VC, de Salazar A, Merino D, Vermehren J, Paolucci S, Kremer A, et al. Journal article A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease (2020) González-Serna D, Ochoa E, López-Isac E, Julià A, Degenhardt F, Ortego-Centeno N, Radstake TR, et al. Journal article GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways (2019) López-Isac E, Acosta-Herrera M, Kerick M, Assassi S, Satpathy AT, Granja J, Mumbach MR, et al. Journal article Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study (2019) Govers TM, Hessels D, Vlaeminck-Guillem V, Schmitz-Draeger BJ, Stief CG, Martinez-Ballesteros C, Ferro M, et al. Journal article PEDIA: prioritization of exome data by image analysis (2019) Hsieh TC, Mensah MA, Pantel JT, Aguilar D, Bar O, Bayat A, Becerra-Solano L, et al. Journal article Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis (2015) Ochoa E, Martin JE, Assassi S, Beretta L, Carreira P, Guillen A, Simeon CP, et al. Journal article